In November, the FDA allowed monoclonal antibodies to be used in emergency situations to treat mild and moderate COVID-19 symptoms in adults and children.
Hospitals across the state, including Mercy Northwest in Rogers, are utilizing this life-saving treatment in an effort to keep more serious cases out of the ICU.
Dr. Sonal Bhakta, Chief Medical Officer at Mercy Medical Center, says the treatment is highly accessible for those that qualify.
Those with chronic health conditions, are over 65 years old, or have any type of immunosuppressive disease, are considered "high risk" and encouraged to seek the treatment.
to the full interview on KUAF.